Citius Pharmaceuticals, Inc. (CTXR) Social Stream



Citius Pharmaceuticals, Inc. (CTXR): $0.66

0.02 (-3.54%)

POWR Rating

Component Grades

Momentum

F

Stability

C

Sentiment

Quality

D

Add CTXR to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#352 of 360

in industry

CITIUS PHARMACEUTICALS INC (CTXR) Price Targets From Analysts

Use the tables below to see what analysts covering CITIUS PHARMACEUTICALS INC think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-12-06 2 $10 $4 $7 $0.741 844.67%
2022-01-03 3 $10 $4 $6 $0.741 709.72%
2022-12-23 3 $10 $6 $8 $0.741 979.62%
2023-04-25 3 $10 $4 $6.666 $0.741 799.6%
2023-06-21 3 $8 $4 $6 $0.741 709.72%
2023-11-02 3 $8 $4 $5.333 $0.741 619.7%

The Trend in the Analyst Price Target


CTXR's average price target has moved down $1.33 over the prior 45 weeks.

Over the past 36 weeks, CTXR's average upside potential has been 469.21%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-03-29 3 10 4 6.666 1.100 506%
2023-04-25 3 10 4 6.666 1.430 366.15%
2023-05-04 3 8 4 6.000 1.250 380%
2023-08-01 3 8 4 5.333 0.955 458.43%
2023-10-24 3 8 4 5.333 0.791 574.21%

CTXR Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 3 0 0 0 0 3

The Trend in the Broker Recommendations


CTXR's average broker recommendation rating improved by 0 over the prior 14 months.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for CTXR as an investment opportunity.

  • In terms of how CITIUS PHARMACEUTICALS INC fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is greater than 673.54% of that group.
  • CITIUS PHARMACEUTICALS INC's average analyst price target is greater than 42.81% of all US stocks.
  • To contextualize these metrics, consider that out of all US stocks, CITIUS PHARMACEUTICALS INC's number of analysts covering the stock is higher than 46.92% of them.
  • CITIUS PHARMACEUTICALS INC's variance in analysts' estimates is lower than -422.48% of stocks in the small market cap category.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to CITIUS PHARMACEUTICALS INC are ABEO, ACIU, and SYRS.

What is the outlook for CTXR? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!